Autopsy report · NCT00503867

SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma

“Low patient recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 8 months before it stopped.
• 10 participants enrolled.
• Results were posted on the registry 10 years 9 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Sirtex Medical

Sponsor type

Industry

Conditions

Carcinoma, Hepatocellular; Hepatoma

Interventions

SIR-Spheres microspheres

Participants

10

Sites

4

Countries

United States

Trials that died the same way

• A Smartphone Application to Improve Medication Adherence Among People With Type 2 Diabetes Mellitus in Singapore
  “Poor patient recruitment” (94% match in meaning)
• The Risk of Intraventricular Hemorrhage With Flat Midline Versus Right-Tilted Flat Lateral Head Positions
  “Due to low patient recruitment” (91% match in meaning)
• Phosphodiesterase (PDE) Inhibitors Effect on Cognitive Deficits Associated to Schizophrenia
  “Patient recruitment insufficient” (89% match in meaning)
• Tibial Delayed Healing Pivotal Clinical Trial
  “Difficulty in patient recruitment” (89% match in meaning)
• Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7)
  “Difficulties in patient recruitment” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.